Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
December 5, 2006

Oxford Gene Technology Tapped to Provide Microarrays for HIV Vaccine Research

  • Oxford Gene Technology (OGT) will design and fabricate microarrays for the Innate Discovery Team as part of the Centre for HIV-AIDS Vaccine Immunology (CHAVI) project.

    OGT will design and develop an optimized oligonucleotide microarray to study genes of interest involved in the cellular immune response in early-stage HIV infected patients. The microarrays will be printed using the OGT ink jet in-situ synthesis platform. It will also investigate the use of its Multi Sample Array format enabling the parallel analysis of multiple samples. This will effectively reduce the cost per sample and speed up sample processing time.

  • Finally! A cure for the Biotech News Blues.

  • Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today’s life science tools and technologies.

  • Oops! Please type your email in the following format: yourname@example.com An error has occurred. Please contact Customer Service at contactGEN@genengnews.com
  • You’re all set! Thank you for subscribing to GEN Highlights.